GSK Posts Paxil Pediatric Data On Website; Plans U.S. Clinical Trial Register
Executive Summary
GlaxoSmithKline's off-the-shelf response to requests for information about off-label use of Paxil in pediatric patients notes that there are studies demonstrating efficacy of paroxetine in obsessive/compulsive disorder and social anxiety disorder
You may also be interested in...
GSK Settles On Paxil Data Disclosure, Will Post Past Study Results By 2006
GlaxoSmithKline will post summaries of studies conducted since the merger of Glaxo Wellcome and SmithKline Beecham by the end of 2005 under a settlement with New York Attorney General Eliot Spitzer
Clinical Trial Database Endorsed By PhRMA; Proposal Coming Soon
The Pharmaceutical Research & Manufacturers of America is endorsing the creation of an industry-wide database to disclose the results of clinical trials for pharmaceutical products
Clinical Trial Database Endorsed By PhRMA; Proposal Coming Soon
The Pharmaceutical Research & Manufacturers of America is endorsing the creation of an industry-wide database to disclose the results of clinical trials for pharmaceutical products